Management Team

We have a small, but highly experienced management team and board of directors around which we have recruited an extensive network of scientific collaborators. 

Douglas J. Jensen, Co-Founder, President and CEO -
     Co-founder and CEO of Origenix Technologies
      Vice President of Administration and Corporate Development at
      Hybridon, Inc.
      Sr. VP Oppenheimer & Company

R. P. "Kris" Iyer, PhD, Co-Founder, Chief Scientific Officer -
     Co-Founder & VP Discovery, Origenix Technologies
       Senior Scientist & Director of Discovery, Hybridon, Inc.
       Research Scientist, NIH

Michael F. Cronin, CPA. CFO -
      Principle of Independent Accounting Firm
        CFO, Operations Director for $60 million six regional chain business
        Turned around financial position and operations for 2 companies

Don Mitchell, MBA, CCO and Vice President, Corporate Development -
         Executive Director, Corp Development, Idenix Pharmaceuticals
         Director of Marketing/Strategic Planning, Amgen
         Principal Consultant, PricewaterhouseCoopers
         Director, Marketing/Business Development, Novartis
       

About Hepatitis

Over 350 million people are chronically infected with HBV virus worldwide. The HBV virus is a DNA virus which incorporates into the hepatocyte DNA. Read More >>

Approximately 170 million people worldwide and 4 million in the United States are infected with HCV. HCV infection is one of the most significant public health threats facing Americans.
Read More >>